CD8A and in situ carcinoma: While p40HD signals through IL-12Rb1 dimers (19), we observed that only about 40% of the CD8+ T cells proliferating within allografts expressed IL-12Rb1, regardless of CIS time conferring low or high IRI-induced inflammation in the allograft (Supplemental Figure 2).